GILD
Gilead Sciences Inc
Gilead Sciences Inc historical holders
total: 12
Matrix Advisors Value Fund Gilead Sciences Inc transactions over time
- Total transactions:
- 15
- New positions:
- 1
- Sold out:
- 1
- Added:
- 7
- Reduced:
- 6
- Held since:
- 2020 Q1
- Held for:
- 17 quarters
- Latest activity:
- 2024 Q2
David Katz has been an institutional investor in Gilead Sciences Inc (GILD) since 2020 Q1. According to 2024 Q4 report, David Katz doesn't hold any shares. The fund/company first acquired GILD in 2020 Q1, initially purchasing 25,175 shares. Since the initial investment, Matrix Advisors Value Fund has made 14 more transactions in this position.
When did David Katz exit their GILD position?
David Katz no longer holds Gilead Sciences Inc (GILD). They sold off their entire position in 2024 Q2, closing out an investment that began in 2020 Q1.
When did David Katz first invest in GILD?
David Katz first invested in Gilead Sciences Inc (GILD) in 2020 Q1 at the reported quarter-end price of $74.76 per share, acquiring 25,175 shares in their initial purchase.
What is David Katz's average cost basis for GILD?
Based on historical transaction data, David Katz's estimated cost basis for Gilead Sciences Inc (GILD) is approximately $74.08 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $74.08
- Weighted AVG sell price:
- $68.69
GILD transactions history by Matrix Advisors Value Fund
15 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q2
|
0.00%
|
0
|
$73.25
|
|
-100% (-17,600)
|
-1.99%
|
|
2024 Q1
|
1.99%
|
17,600
|
$73.25
|
$1,289,200
|
+12.82% (+2,000)
|
+0.23%
|
|
2023 Q4
|
2.09%
|
15,600
|
$81.01
|
$1,263,756
|
-16.13% (-3,000)
|
-0.45%
|
|
2023 Q3
|
2.60%
|
18,600
|
$74.94
|
$1,393,884
|
+20.39% (+3,150)
|
+0.44%
|
|
2023 Q2
|
2.09%
|
15,450
|
$77.07
|
$1,190,732
|
+4.39% (+650)
|
+0.09%
|
|
2023 Q1
|
2.24%
|
14,800
|
$82.97
|
$1,227,956
|
+146.67% (+8,800)
|
+1.33%
|
|
2022 Q3
|
0.76%
|
6,000
|
$61.69
|
$370,140
|
-42.31% (-4,400)
|
-0.51%
|
|
2022 Q2
|
1.21%
|
10,400
|
$61.81
|
$642,824
|
-63.38% (-18,000)
|
-1.69%
|
|
2021 Q4
|
2.93%
|
28,400
|
$72.61
|
$2,062,124
|
-9.98% (-3,150)
|
-0.34%
|
|
2021 Q3
|
3.28%
|
31,550
|
$69.85
|
$2,203,768
|
-1.41% (-450)
|
-0.05%
|
|
2021 Q1
|
3.42%
|
$64.63
|
+32.78% (+7,900)
|
|||
|
2020 Q4
|
2.61%
|
$58.26
|
+2.55% (+600)
|
|||
|
2020 Q3
|
3.14%
|
$63.19
|
+5.86% (+1,300)
|
|||
|
2020 Q2
|
3.55%
|
$76.94
|
-11.82% (-2,975)
|
|||
|
2020 Q1
|
4.76%
|
$74.76
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.